Quantedge Capital Pte Ltd - CORCEPT THERAPEUTICS INC ownership

CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 235 filers reported holding CORCEPT THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.63 and the average weighting 0.1%.

Quarter-by-quarter ownership
Quantedge Capital Pte Ltd ownership history of CORCEPT THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$1,180,730
-76.9%
54,512
-78.3%
0.46%
-73.1%
Q4 2022$5,104,147
-18.3%
251,312
+3.1%
1.71%
-11.2%
Q3 2022$6,249,000
-19.0%
243,712
-24.9%
1.93%
+23.9%
Q2 2022$7,715,000
+203.1%
324,412
+187.1%
1.56%
+106.8%
Q1 2022$2,545,000
+739.9%
113,012
+638.1%
0.75%
+487.5%
Q4 2021$303,00015,3120.13%
Other shareholders
CORCEPT THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
INGALLS & SNYDER LLC 6,911,376$155,644,0006.95%
Parallel Advisors, LLC 1,944,319$47,014,0001.86%
TANAKA CAPITAL MANAGEMENT INC 39,289$885,0001.79%
S&T BANK/PA 508,546$11,452,0001.73%
Bridge City Capital, LLC 83,967$1,891,0000.88%
Birchview Capital, LP 50,000$1,126,0000.81%
Quantedge Capital Pte Ltd 113,012$2,545,0000.75%
FAS Wealth Partners, Inc. 289,625$6,522,0000.61%
AJ WEALTH STRATEGIES, LLC 396,029$8,919,0000.44%
TRUSTCORE FINANCIAL SERVICES, LLC 208,806$4,702,0000.41%
View complete list of CORCEPT THERAPEUTICS INC shareholders